Carbamates of formula (I) or pharmaceutically acceptable salts thereof, including quaternary ammonium salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
本文披露了式(I)的
氨基甲酸酯或其药学上可接受的盐,包括式(II)的季
铵盐,以及它们的制备过程、包含它们的制药组合物以及它们作为M3
胆碱能受体拮抗剂在治疗中的应用。